Enbrel 50 MG/ML sureclickml

Ended Awarded Last action

Contract number
SPE2DR26FM2UR
Awardee
Awarding agency
Obligated
$25,748

Award facts

Contract value 100% obligated
$25,747.95 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

On January 20, 2026, the Defense Logistics Agency awarded a delivery order valued at $25,747.95 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside contract is scheduled for completion by January 21, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This contract reflects routine pharmaceutical procurement through the Defense Logistics Agency's established supply chain for specialty medications. Enbrel, a immunosuppressant biologic used to treat rheumatoid arthritis and other autoimmune conditions, represents the type of specialized medical commodity regularly distributed to military treatment facilities and veteran healthcare programs through the DLA Troop Support Medical contract vehicle. AmerisourceBergen's role as a pharmaceutical prime vendor demonstrates its continued capability to fulfill federal requirements for essential medications across multiple therapeutic domains on a competitively awarded basis.

Quick answers

Who was awarded contract SPE2DR26FM2UR?

SPE2DR26FM2UR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.

How much is contract SPE2DR26FM2UR worth?

The government has obligated $25,748 on SPE2DR26FM2UR.

Is contract SPE2DR26FM2UR an order under another contract?

Yes. SPE2DR26FM2UR is a delivery order under SPE2DR25D3501, an indefinite delivery contract.

Was contract SPE2DR26FM2UR competed?

The extent of competition for SPE2DR26FM2UR was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award